In regards to the market reacting to small earnings for 1st q. or even 2nd q. in 2022, I can't imagine why that would pose as a problem. The reaction from the market would derive predominately from the longs and otc players, knowing fundamentals don't always drive the share price and valuation for otc companies, especially when when any company is just getting started. In fact, it'll further cement the legitimacy of the company and will be viewed positive more than anything else...
It goes extensively beyond that when you consider the s.p or valuation for an otc company, but a lot of them have huge debts, no earnings, dilution, fraudulent claims, fraudilent activities, fraudulent plauers and still have hundreds of millions of dollars in market cap, if not billions...
Market Data 
Markets 
